Filing Details
- Accession Number:
- 0001140361-13-035677
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-11 18:01:40
- Reporting Period:
- 2013-09-09
- Filing Date:
- 2013-09-11
- Accepted Time:
- 2013-09-11 18:01:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1228627 | Rexahn Pharmaceuticals Inc. | RNN | Pharmaceutical Preparations (2834) | 113516358 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1317190 | Heum Tae Jeong | C/O Rexahn Pharmaceuticals, Inc. 15245 Shady Grove Road, Suite 455 Rockville MD 20850 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-09-09 | 150,000 | $0.24 | 655,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-09-09 | 78,861 | $0.46 | 576,139 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2013-09-09 | 71,139 | $0.46 | 505,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to purchase) | Disposition | 2013-09-09 | 150,000 | $0.00 | 150,000 | $0.24 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-10-04 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to purchase) | $0.31 | 2023-03-01 | 250,000 | 250,000 | Direct | |
| Common Stock | Stock Option (right to purchase) | $0.78 | 2018-12-11 | 250,000 | 250,000 | Direct | |
| Common Stock | Stock Option (right to purchase) | $0.80 | 2015-01-20 | 500,000 | 500,000 | Direct | |
| Common Stock | Stock Option (right to purchase) | $0.80 | 2005-12-01 | 2013-10-04 | 100,000 | 100,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2023-03-01 | 250,000 | 250,000 | Direct |
| 2018-12-11 | 250,000 | 250,000 | Direct |
| 2015-01-20 | 500,000 | 500,000 | Direct |
| 2013-10-04 | 100,000 | 100,000 | Direct |
Footnotes
- Reflects shares withheld by the issuer at the weighted average sales price of 0.4565 per share to fund the cashless exercise of 150,000 options.
- Options will vest and be exercisable based on the following schedule: 75,000 on March 1, 2014, 75,000 on March 1, 2015, and 100,000 on March 1, 2016.
- Options vested and became exercisable based on the following schedule 75,000 on December 11, 2009, 75,000 on December 11, 2010, and 100,000 on December 11, 2011.
- Options vested and became exercisable based on the following schedule 150,000 on January 20, 2006, 150,000 on January 20, 2007, and 200,000 on January 20, 2008.
- Options were due to expire on August 5, 2003, however, the Compensation Committee of the Board of Directors of Rexahn Pharmaceuticals, Inc. (the "Company") extended the expiration date because the Company was in a blackout period at that time. The expiration date was extended to 30 days from the end of the blackout period, which is October 4, 2013.
- Options vested and became exercisable based on the following schedule 75,000 on December 1, 2003 and 75,000 on December 1, 2004.
Billionaire Hedge Funds
